BFIAX
Price
$9.49
Change
-$0.05 (-0.52%)
Updated
Jun 5 closing price
Net Assets
13.13B
CNLCX
Price
$9.51
Change
-$0.04 (-0.42%)
Updated
Jun 5 closing price
Net Assets
13.13B
Interact to see
Advertisement

BFIAX vs CNLCX

Header iconBFIAX vs CNLCX Comparison
Open Charts BFIAX vs CNLCXBanner chart's image
BFIAX vs CNLCX Comparison Chart in %
View a ticker or compare two or three
VS
BFIAX vs. CNLCX commentary
Jun 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFIAX is a Hold and CNLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BFIAX (13.1B) and CNLCX (13.1B) have equal amount of cash in the bank . BFIAX pays higher dividends than CNLCX: BFIAX (3.26) vs CNLCX (2.34). BFIAX was incepted earlier than CNLCX: BFIAX (13 years) vs CNLCX (11 years). CNLCX (1.44) is less costly to investors than BFIAX (0.66). BFIAX (12.00) and CNLCX (12.00) have comparable annual turnover. BFIAX (250) and CNLCX (250) have matching initial minimum investment requirements. BFIAX annual gain was more profitable for investors over the last year : 4.51 vs. CNLCX (3.56). BFIAX return over 5 years is better than : 1.43 vs. CNLCX (-2.40).
BFIAXCNLCXBFIAX / CNLCX
Total Expense Ratio0.661.4446%
Annual Report Gross Expense Ratio0.661.4446%
Fund Existence13 years11 years-
Gain YTD1.2740.951134%
Front Load3%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets13.1B13.1B100%
Annual Yield % from dividends3.262.34139%
Returns for 1 year4.513.56127%
Returns for 3 years10.768.17132%
Returns for 5 years1.43-2.40-60%
Returns for 10 years23.0814.07164%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERCX65.23N/A
N/A
American Funds EUPAC R3
PHSZX46.53N/A
N/A
PGIM Jennison Health Sciences Z
WSBFX24.32N/A
N/A
Boston Trust Walden Balanced
JWWCX126.25N/A
N/A
Janus Henderson Global Research C
MATFX27.36N/A
N/A
Matthews Asia Innovators Investor